Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. 1998

T Nakao, and H Matsumoto, and T Okada, and M Han, and H Hidaka, and M Yoshino, and T Shino, and C Yamada, and Y Nagaoka
Department of Nephrology, Tokyo Medical University.

We studied the influence of erythropoietin (EPO) treatment on hemoglobin A1c (HbA1c) levels under conditions which eliminate the effect of changes in the blood glucose concentration. HbA1c levels, blood glucose, hematocrit (Hct) and reticulocyte counts were serially measured every two weeks after starting or stopping EPO administration in 15 non-diabetic hemodialysis patients. EPO treatment significantly influenced HbA1c levels, and the more erythropoiesis fluctuated by changing the dose of EPO, the more HbA1c levels changed, though there were no significant changes in blood glucose levels during the study period. The changes in HbA1c during the 2-week period correlated inversely with both the changes in Hct during the same 2 weeks and the reticulocyte counts at that time. We concluded that the change in Hct should be kept in mind when the HbA1c level is evaluated in EPO-treated patients and a formula should be proposed to correct HbA1c levels based on the change in Hct or the reticulocyte count.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D004920 Erythropoiesis The production of red blood cells (ERYTHROCYTES). In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction. Erythropoieses
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005260 Female Females
D006400 Hematocrit The volume of packed RED BLOOD CELLS in a blood specimen. The volume is measured by centrifugation in a tube with graduated markings, or with automated blood cell counters. It is an indicator of erythrocyte status in disease. For example, ANEMIA shows a low value; POLYCYTHEMIA, a high value. Erythrocyte Volume, Packed,Packed Red-Cell Volume,Erythrocyte Volumes, Packed,Hematocrits,Packed Erythrocyte Volume,Packed Erythrocyte Volumes,Packed Red Cell Volume,Packed Red-Cell Volumes,Red-Cell Volume, Packed,Red-Cell Volumes, Packed,Volume, Packed Erythrocyte,Volume, Packed Red-Cell,Volumes, Packed Erythrocyte,Volumes, Packed Red-Cell
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006442 Glycated Hemoglobin Products of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN (occurring as a minor fraction of the hemoglobin of ERYTHROCYTES.) It generally refers to glycated HEMOGLOBIN A. Hemoglobin A1c (Hb A1c) is hemoglobin A with GLYCATION on a terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes. Fructated Hemoglobins,Glycohemoglobin,Glycohemoglobin A,Glycohemoglobins,Glycosylated Hemoglobin A,Hb A1c,HbA1,Hemoglobin A(1),Hemoglobin A, Glycosylated,Glycated Hemoglobin A,Glycated Hemoglobin A1c,Glycated Hemoglobins,Glycosylated Hemoglobin A1c,Hb A1,Hb A1a+b,Hb A1a-1,Hb A1a-2,Hb A1b,Hemoglobin, Glycated A1a-2,Hemoglobin, Glycated A1b,Hemoglobin, Glycosylated,Hemoglobin, Glycosylated A1a-1,Hemoglobin, Glycosylated A1b,A1a-1 Hemoglobin, Glycosylated,A1a-2 Hemoglobin, Glycated,A1b Hemoglobin, Glycated,A1b Hemoglobin, Glycosylated,Glycated A1a-2 Hemoglobin,Glycated A1b Hemoglobin,Glycosylated A1a-1 Hemoglobin,Glycosylated A1b Hemoglobin,Glycosylated Hemoglobin,Hemoglobin A, Glycated,Hemoglobin A1c, Glycated,Hemoglobin A1c, Glycosylated,Hemoglobin, Glycated,Hemoglobin, Glycated A1a 2,Hemoglobin, Glycosylated A1a 1,Hemoglobins, Fructated,Hemoglobins, Glycated

Related Publications

T Nakao, and H Matsumoto, and T Okada, and M Han, and H Hidaka, and M Yoshino, and T Shino, and C Yamada, and Y Nagaoka
February 1997, The International journal of artificial organs,
T Nakao, and H Matsumoto, and T Okada, and M Han, and H Hidaka, and M Yoshino, and T Shino, and C Yamada, and Y Nagaoka
January 1977, Hemoglobin,
T Nakao, and H Matsumoto, and T Okada, and M Han, and H Hidaka, and M Yoshino, and T Shino, and C Yamada, and Y Nagaoka
September 2004, Journal of endocrinological investigation,
T Nakao, and H Matsumoto, and T Okada, and M Han, and H Hidaka, and M Yoshino, and T Shino, and C Yamada, and Y Nagaoka
January 1993, Nephron,
T Nakao, and H Matsumoto, and T Okada, and M Han, and H Hidaka, and M Yoshino, and T Shino, and C Yamada, and Y Nagaoka
October 2003, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
T Nakao, and H Matsumoto, and T Okada, and M Han, and H Hidaka, and M Yoshino, and T Shino, and C Yamada, and Y Nagaoka
July 2004, Journal of the American Society of Nephrology : JASN,
T Nakao, and H Matsumoto, and T Okada, and M Han, and H Hidaka, and M Yoshino, and T Shino, and C Yamada, and Y Nagaoka
January 1996, Przeglad lekarski,
T Nakao, and H Matsumoto, and T Okada, and M Han, and H Hidaka, and M Yoshino, and T Shino, and C Yamada, and Y Nagaoka
July 1982, The American journal of medicine,
T Nakao, and H Matsumoto, and T Okada, and M Han, and H Hidaka, and M Yoshino, and T Shino, and C Yamada, and Y Nagaoka
December 1992, Polskie Archiwum Medycyny Wewnetrznej,
T Nakao, and H Matsumoto, and T Okada, and M Han, and H Hidaka, and M Yoshino, and T Shino, and C Yamada, and Y Nagaoka
September 2002, Clinical and experimental nephrology,
Copied contents to your clipboard!